Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.

Genetic and environmental factors, like smoking and exercise, affect male hair loss.

New treatments for hair loss show promise, especially finasteride for men and a stronger minoxidil formula.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

Male hormones cause different growth in identical human hair follicles due to their unique epigenetic characteristics.

Androgens improve memory in adolescent male rats by acting on brain receptors.

Thyroid hormones and androgens affect gene expression in frog reproductive organs differently between males and females.

Testosterone therapy for transmasculine individuals is generally safe with medical supervision, improves mental health, and has mixed effects on physical health.

Brassica oleracea extract, glucosinlates, and sulforaphane can boost hair growth and might be used to treat hair loss.

Flutamide and a new synthetic steroid affected brain and prostate chemicals and showed potential for treating androgen-related conditions and epilepsy.

Hormonal changes and psychological issues can cause sexual dysfunction in postmenopausal women. Behavioral therapy is recommended first, with hormone replacement helping some symptoms but not libido. Testosterone can improve libido, but its effects on overall sexual function are unclear. Emotional and relationship issues should be addressed before using medication, and the benefits and risks of testosterone supplementation should be considered.

A pineal tumor caused a boy's early puberty, which changed from peripheral to central after treatment.

Females with 5 alpha-reductase-2 deficiency have less body hair, no acne, normal fertility, and delayed menarche.

Women with PCOS often have more body hair, acne, and skin darkening, and these signs are linked to metabolic issues like insulin resistance and high cholesterol.

Dietary changes, including weight loss and a balanced diet, are important for managing PCOS, especially in overweight women.

Excessive hair growth can be assessed by history, exam, and blood tests, and treated with medication like dexamethasone, birth control pills, and spironolactone.

Treatment with a hormone agonist can reduce excess male hormones in postmenopausal women without surgery.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.

Human sebaceous glands contain enzymes that affect androgen production and may influence sebum production and acne.

The substance MK386 effectively blocked testosterone conversion and reduced cell growth in certain skin cells, but inhibiting 5α-reductase alone may not greatly improve acne.

The review highlights the need for more research on transgender dermatology, the role of dermatologists in gender affirmation, and the effects of hormone therapy on skin and hair.

5α-Reductase inhibitors can help treat hair loss, acne, and prostate issues by reducing DHT levels.

There are various effective hormone treatments for puberty induction in boys and girls with hypogonadism, and starting treatment early is important.

Managing oxidative stress might help treat low testosterone and related chronic diseases in aging men.

Androgens and SARMs play a role in body mass, frailty, skin health, and hair growth, and are used in treating prostate cancer, acne, and hair loss, with potential for new uses and improved versions in the future.

Nandrolone and oxandrolone could help treat male health issues like muscle loss and low testosterone.

Liquorice may reduce testosterone and affect male reproductive organs, potentially helping treat conditions like prostate cancer.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

High doses of nandrolone decanoate disrupt ovarian hormones and receptors in rats, with recovery only at lower doses and longer recovery times.

Patients with PCOS tend to score their hirsutism higher than clinicians, making self-scoring less useful for diagnosis.